Introduction
MT-ND1
| Full Name | Mitochondrially Encoded NADH Dehydrogenase Subunit 1 |
|---|---|
| Chromosomal Location | mitochondrial genome (MT:3307-4262) |
| NCBI Gene ID | [4535](https://www.ncbi.nlm.nih.gov/gene/4535) |
| OMIM | [516000](https://www.omim.org/entry/516000) |
| Ensembl ID | ENSG00000188188 |
| UniProt | [P03927](https://www.uniprot.org/uniprot/P03927) |
| Associated Diseases | Leber's Hereditary Optic Neuropathy, MELAS Syndrome, Parkinson's Disease |
Overview
MT-ND1 (Mitochondrially Encencoded NADH Dehydrogenase 1) is a core subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase)1Mitochondrial diseases in man and mouseOpen reference. It is one of 7 mtDNA-encoded subunits of Complex I and is critical for electron transfer and oxidative phosphorylation2Mitochondrial diseaseOpen reference.
Function
The MT-ND1 gene encodes a 318-amino acid membrane protein:
-
Complex I subunit: Forms part of the membrane arm of NADH dehydrogenase
-
Electron transfer: Transfers electrons from NADH to ubiquinone
-
Proton pumping: Contributes to proton gradient generation
-
Evolutionary origin: Retained from bacterial ancestor of mitochondria
-
Conservation: Highly conserved across eukaryotes
Disease Associations
Leber’s Hereditary Optic Neuropathy (LHON)
-
Primary mutations: m.3460G>A (ND1) is a common cause of LHON3Mitochondrial respiratory-chain diseasesOpen reference
-
Penetrance: ~40-50% of males and 10-15% of females with mutation develop optic neuropathy
-
Age of onset: Typically 15-35 years
-
Selective vulnerability: Retinal ganglion cells are particularly susceptible
MELAS Syndrome
-
m.3243A>G: Most common MELAS mutation affects MT-TL1, but ND1 mutations can contribute
-
Features: Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes
Parkinson’s Disease
-
Complex: Post-mort I deficiencyem PD brains show reduced Complex I activity4Mitochondrial DNA mutations in human diseaseOpen reference
-
ND1 variants: Some ND1 variants may increase PD risk or modify phenotype
-
Mitochondrial dysfunction: Early event in PD pathogenesis
Expression
MT-ND1 is expressed in all tissues with high mitochondrial content:
-
Retina and optic nerve
-
Heart
-
Skeletal muscle
-
Brain (cerebral cortex)
-
Liver
-
Kidney
Key Publications
-
1Mitochondrial diseases in man and mouseOpen reference: Wallace DC et al. (1988). Mitochondrial DNA mutations in Leber’s hereditary optic neuropathy. Science
-
2Mitochondrial diseaseOpen reference: Chinnery PF et al. (2015). Mitochondrial disorders. Lancet
-
3Mitochondrial respiratory-chain diseasesOpen reference: Yu-Wai-Man P et al. (2011). LHON and other mitochondrial optic neuropathies. Prog Retin Eye Res
-
4Mitochondrial DNA mutations in human diseaseOpen reference: Schapira AH et al. (1989). Mitochondrial complex I deficiency in Parkinson’s disease. Lancet
Cross-links
Background
The study of Mt Nd1 Gene Mitochondrial Nadh Dehydrogenase Subunit 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
External Links
References
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.